
Ty Miller Lab
@tymillerlab
tymillerlab.org @CWRUSOM @UHhospitals | Researchers of #braincancer, myeloid cells, epigenetics, #immunotherapy |
Dedicated to finding cures for patients
ID: 724865113
https://tymillerlab.org 29-07-2012 23:55:54
1,1K Tweet
1,1K Followers
515 Following



We are excited to share our new study Cancer Cell identifying Zeb2 as a master genetic switch controlling the tumor-associated macrophage (TAM) program. Led by Fadi Sheban, T. San Phan, Ken Xie & Florian Ingelfinger. (1/20) cell.com/cancer-cell/fu…



Thanks to Charles Couturier, MD, PhD & Ella Marushchenko for the collaboration on this cover submission for our Nature Magazine paper in this week's issue! We love the image and concept! Charles and I are building on this work in our new labs Case Comp Cancer Ctr / CWRU School of Medicine and McGill University - join our teams!

Just read this start to finish - bravo Jonathan Kipnis 💔🎗️ and Leon Smyth! So well written that I didn't want to stop to look at the figures until the end. Having everyone in my lab read it!


Celebrating a great day of science at #CPCSRC FASEB - scientific discussions continuing with a view! Ty Miller Lab Sendurai Mani Walid Khaled Karuna Ganesh Shaheen Sikandar Loic Deleyrolle, PhD Praj Rajappa M.D., M.S.


Excited to see our latest study on the immune landscape of pediatric high-grade glioma patients out! Tweetorial from fabulous Rebecca Pötschke below 👇🏻, we hope this will useful to many in the field! Dana-Farber/Boston Children's Boston Children's Dana-Farber Broad Institute #endbraincancer

Great AM session on the last day of #CPCSRC FASEB with exciting myeloid cell plasticity in brain tumors from Ty Miller Lab Praj Rajappa M.D., M.S.





X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

As Chair of the Oxford-Harrington Rare Disease Centre Centre’s Advisory Board, I was delighted to join global medical leaders & researchers at the Harrington Discovery Institute & University Hospitals Scientific Symposium in Cleveland, Ohio this week. Rare disease & Alzheimer’s have been a focus personally & professionally

